{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:50:16Z","timestamp":1789627816897,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.radonc.2025.111200","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:09:27Z","timestamp":1759622967000},"page":"111200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative report"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5727-7594","authenticated-orcid":false,"given":"Jillian R.","family":"Gunther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna C.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Hajj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea K.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7668-3296","authenticated-orcid":false,"given":"Mario","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"George Mikhaeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4406-7621","authenticated-orcid":false,"given":"Umberto","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Illidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Turin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3953-2173","authenticated-orcid":false,"given":"Mark","family":"Knafl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6902-2190","authenticated-orcid":false,"given":"Lena","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bouthaina Shbib","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111200_b0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/imj.14859","article-title":"Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic","volume":"50","author":"Di Ciaccio","year":"2020","journal-title":"Intern Med J"},{"key":"10.1016\/j.radonc.2025.111200_b0010","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3389\/fonc.2020.01439","article-title":"Management of Patients with Hematologic Malignancies during the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned","volume":"10","author":"Isidori","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0015","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.canrad.2019.09.002","article-title":"Hypofractionated radiation therapy for invasive breast cancer: from moderate to extreme protocols","volume":"23","author":"Rivera","year":"2019","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.radonc.2025.111200_b0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.radonc.2025.111200_b0025","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood.2020006028","article-title":"ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic","volume":"135","author":"Yahalom","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2025.111200_b0030","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s11547-021-01414-z","article-title":"Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model","volume":"126","author":"Cellini","year":"2021","journal-title":"Radiol Med"},{"key":"10.1016\/j.radonc.2025.111200_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2021.103402","article-title":"Radiotherapy based management during Covid-19 pandemic \u2013 a systematic review of presented consensus and guidelines","volume":"164","author":"Siavashpour","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2025.111200_b0040","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ajco.13456","article-title":"Radiation oncology during COVID-19: strategies to avoid compromised care","volume":"17","author":"Horsley","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.radonc.2020.06.033","article-title":"Prioritization on palliative radiotherapy during the COVID-19 pandemic (and beyond)","volume":"150","author":"Cellini","year":"2020","journal-title":"Radiotherapy Oncol: J Euro Soc Therapeutic Radiol Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0050","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s00066-020-01705-w","article-title":"Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic : Expert recommendations from the radiation oncology panels of the German Hodgkin Study Group and the German Lymphoma Alliance","volume":"196","author":"Oertel","year":"2020","journal-title":"Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al]"},{"key":"10.1016\/j.radonc.2025.111200_b0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.radonc.2025.111200_b0060","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.19.00964","article-title":"Positron Emission Tomography-Guided Treatment in Early-Stage favorable Hodgkin Lymphoma: final results of the International, Randomized phase III HD16 Trial by the German Hodgkin Study Group","volume":"37","author":"Fuchs","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0065","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0070","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.e18077","article-title":"Building a data foundation: how MD Anderson and Palantir are partnering to accelerate research and improve patient care","author":"Alfaro-Munoz","year":"2019","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0075","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/curroncol31010025","article-title":"Hypofractionated radiotherapy for hematologic malignancies during the COVID-19 pandemic and beyond","volume":"31","author":"Antony","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0080","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1016\/j.ijrobp.2019.06.1444","article-title":"The efficacy of hypofractionated radiotherapy for local control in aggressive non-Hodgkin Lymphoma","volume":"105","author":"Takahashi","year":"2019","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1016\/j.radonc.2025.111200_b0085","article-title":"Radiation therapy for relapsed or refractory diffuse large B-Cell Lymphoma: what is the right Regimen for Palliation?","volume":"7","author":"Wright","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/bjh.16541","article-title":"Early experience using salvage radiotherapy for relapsed\/refractory non-Hodgkin lymphomas after CD19 chimericantigen receptor (CAR)T cell therapy","volume":"190","author":"Imber","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.radonc.2025.111200_b0095","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.jtct.2022.12.021","article-title":"Bridging radiation rapidly and effectively cytoreduces high-risk relapsed\/refractory aggressive B Cell Lymphomas prior to chimeric antigen receptor T Cell Therapy","volume":"29","author":"Hubbeling","year":"2023","journal-title":"Transplant cell therapy"},{"key":"10.1016\/j.radonc.2025.111200_b0100","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00432-020-03449-7","article-title":"Acute and sub-acute toxicity profile of ultra-hypofractionated low-dose total skin electron beam with two 4 Gy fractions for cutaneous T cell lymphoma","volume":"147","author":"Rolf","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0105","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/j.prro.2020.08.001","article-title":"Low-Dose hypofractionated total skin electron beam therapy for adult cutaneous T-Cell lymphoma","volume":"10","author":"Jeans","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1159\/000516570","article-title":"Safety and feasibility analysis of a prospective trial on stereotactic body radiotherapy for solitary bone plasmacytoma","volume":"144","author":"Mauro","year":"2021","journal-title":"Acta Haematol"},{"key":"10.1016\/j.radonc.2025.111200_b0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3171\/2016.8.SPINE16412","article-title":"Spine stereotactic radiosurgery for the treatment of multiple myeloma","volume":"26","author":"Miller","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.radonc.2025.111200_b0120","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2018.05.009","article-title":"Radiation therapy for solitary plasmacytoma and multiple myeloma: guidelines from the international lymphoma radiation oncology group","volume":"101","author":"Tsang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111200_b0125","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/curroncol28050288","article-title":"COVID-19 Pandemic-adapted radiotherapy guidelines: are they really Followed?","volume":"28","author":"Galofaro","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0130","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1212\/WNL.39.6.789","article-title":"Radiation-induced dementia in patients cured of brain metastases","volume":"39","author":"DeAngelis","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.radonc.2025.111200_b0135","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fonc.2012.00073","article-title":"Radiation-induced brain injury: a review","volume":"2","author":"Greene-Schloesser","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2025.111200_b0140","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijrobp.2020.02.633","article-title":"Radiation-Induced lymphopenia predicts poorer prognosis in patients with breast cancer: a post hoc analysis of a randomized controlled trial of postmastectomy hypofractionated radiation therapy","volume":"108","author":"Sun","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111200_b0145","article-title":"Radiation and CAR T-cell Therapy in Lymphoma: Future frontiers and potential opportunities for synergy","volume":"11","author":"Fang","year":"2021","journal-title":"Front Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025052041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:14:17Z","timestamp":1780546457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025052041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"alternative-id":["S0167814025052041"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111200","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and toxicity of hypofractionated radiation therapy for patients with hematologic malignancies: A COVID-era ILROG collaborative report","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111200"}}